The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 Names of Reporting Persons.

 David Hung, M.D.

 Check the Appropriate Box if a Member of a Group (See Instructions)

 (a) ☐  (b) ☐

 SEC Use Only

 Source of Funds (See Instructions)

 OO

 Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 ☐

 Citizenship or Place of Organization

 United States

Number of

Shares  Beneficially 

Owned by

Each

Reporting

Person

With

 Sole Voting Power

  61,269,498

 Shared Voting Power

 0

 Sole Dispositive Power

  61,269,498

 Shared Dispositive Power

 0

 Aggregate Amount Beneficially Owned by Each Reporting Person

  61,269,498

 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 ☐

 Percent of Class Represented by Amount in Row (11)

 27.7%(1)

 Type of Reporting Person (See Instructions)

 IN

This percentage is calculated based upon 218,046,219 shares of Class A common stock and 1,000,0000 shares of Class B common stock outstanding as of February 16, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on February 29, 2024.

the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;

an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;

a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries;

any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board;

any material change in the present capitalization or dividend policy of the Issuer;

any other material change in the Issuer’s business or corporate structure, including but not limited to, if the Issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the Investment Company Act of 1940;

changes in the Issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person;

causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;

a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or

any action similar to any of those enumerated above.

As of March 25, 2024, the Reporting Person beneficially owns 61,269,498 shares of Class A Common Stock of the Issuer, comprising (i) 58,281,054 outstanding shares of Class A Common Stock, (ii) 1,000,000 outstanding shares of Class B Common Stock, $0.0001 par value per share, of the Issuer (“Class B Common Stock”), which are convertible at the holder’s option (and automatically under certain circumstances) into 1,000,000 shares of Class A Common Stock, and (iii) outstanding options exercisable for 1,988,444 shares of Class A Common Stock within 60 days after March 24, 2024, which in aggregate represents approximately 27.7% of the Class A Common Stock and 100% of the Class B Common Stock, respectively, outstanding as of February 29, 2024. These percentages are calculated in accordance with SEC rules and are based on 218,046,219 shares of Class A Common Stock and 1,000,000 shares of Class B Common Stock outstanding as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on February 29, 2024.

Schedule / Form

File No.

Exhibit

Filing Date

F. Voting Agreement

G. Letter Agreement

Agreement Regarding Certain Board Matters

During the Term:

Dr. Hung, in his capacity as the holder of the Class B Shares, shall vote, or cause to be voted, all Class B Shares then owned by Dr. Hung, or over which Dr. Hung has voting control, in whatever manner as shall be necessary to ensure that, at each annual or special meeting of stockholders of Parent at which an election of directors is held and at which Dr. Wang’s term as a Class B Director (as defined in Parent’s Amended and Restated Certificate of Incorporation) would otherwise expire, (i) Dr. Wang is nominated to serve as a Class B Director, and (ii) Dr. Wang is re-elected and re-appointed to the Board as a Class B Director.

Dr. Hung, in his capacity as the holder of the Class B Shares, shall vote, or cause to be voted, all Class B Shares then owned by Dr. Hung, or over which Dr. Hung has voting control, in whatever manner as shall be necessary to ensure that Dr. Wang is not removed from the Board, except for Cause.

For the avoidance of doubt, Dr. Wang shall not be eligible for compensation for his service as a member of the Board, but Dr. Wang shall be eligible for reimbursement of expenses incurred in connection with his service as a Class B Director, including his attendance at meetings of the Board, in accordance with the policies of the Board.

This Agreement shall be terminated and of no further force or effect upon the earlier of (a) the mutual written agreement to terminate this Agreement between the parties hereto and (b) the termination of the Merger Agreement in accordance with Section 9 thereof.

In this Agreement:

“Cause” means Dr. Wang’s: (i) intentional and unauthorized use or disclosure of Parent’s or its Affiliates’ (including, after the Closing, the Company) confidential information or trade secrets, which use or disclosure causes material harm to Parent or its Affiliates; (ii) conviction of any felony under the laws of the United States or any state thereof; (iii) willful participation in a material fraud against Parent or its Affiliates; (iv) gross negligence or willful misconduct which causes material harm to Parent; (v) intentional and material damage to Parent’s or its Affiliates’ property; (vi) sustained and material failure to perform the duties customarily associated with his position with Parent or its Affiliates that has not been cured within thirty (30) days after written notice from Parent or the Board of such failure; or (vii) material breach of any agreement with Parent or its Affiliates that has not been cured within thirty (30) days after written notice from Parent or the Board.

“Term” means the period from the date hereof until the earlier of (i) the second anniversary of the Closing and (ii) the date Dr. Wang ceases to be employed by, and ceases to provide services to (other than services provided in Dr. Wang’s capacity as Class B Director), Parent or any of its Affiliates.

This Agreement constitutes the complete and exclusive statement regarding the subject matter of this Agreement and supersedes all prior agreements, understandings and communications, oral or written, between the parties regarding the subject matter of this Agreement. No party may assign (by operation of law or otherwise) either this Agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other party. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. Any purported assignment in violation of this Agreement shall be void ab initio.

No waiver of any provisions hereof by either party hereto shall be deemed a waiver of any other provisions hereof by any such party, nor shall any such waiver be deemed a continuing waiver of any provision hereof by such party. This Agreement may be amended by written agreement of all parties hereto.

This Agreement shall be interpreted, construed and governed by and in accordance with the Laws of the State of Delaware without regard to the conflicts of law principles thereof that would subject such matter to the Laws of another jurisdiction.

Dr. Hung acknowledges and agrees that Dr. Wang will be irreparably damaged in the event any of the provisions of this Agreement are not performed by the parties in accordance with their specific terms or are otherwise breached. Accordingly, it is agreed that Dr. Wang shall be entitled to an injunction to prevent breaches of this Agreement, and to specific enforcement of this Agreement and its terms and provisions in any action instituted in any court of the United States or any state having subject matter jurisdiction, subject to paragraph 8. Each party to this Agreement agrees to use commercially reasonable efforts to cooperate in seeking and agreeing to an expedited schedule in any litigation seeking an injunction or order of specific performance.

Each of the parties irrevocably and unconditionally agrees that any legal action or proceeding with respect to this Agreement and the rights and obligations arising hereunder, or for recognition and enforcement of any judgment in respect of this Agreement and the rights and obligations arising hereunder brought by any party or its successors or assigns, shall be brought and determined exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware (or, solely if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any state or federal court within the State of Delaware). Each of the parties hereby irrevocably and unconditionally submits with regard to any such action or proceeding for itself and in respect of its property to the personal jurisdiction of the aforesaid courts and agrees that it will not bring any action relating to this Agreement in any court other than the aforesaid courts. Each of the parties hereby irrevocably waives, and agrees not to assert, by way of motion, as a defense, counterclaim or otherwise, in any action or proceeding with respect to this Agreement, (a) any claim that it is not personally subject to the jurisdiction of the above named courts, (b) any claim that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) to the fullest extent permitted by applicable Law, any claim that (i) the suit, action or proceeding in such court is brought in an inconvenient forum, (ii) the venue of such suit, action or proceeding is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts. To the fullest extent permitted by applicable Law, each of the parties hereto hereby consents to the service of process in accordance with this paragraph 8; provided, that nothing herein shall affect the right of any party to serve legal process in any other manner permitted by applicable Law.

/s/ David Hung

/s/ Junyuan Jerry Wang